Beca, FranciscoBeck, Andrew2017-01-032016Beca, Francisco, and Andrew H. Beck. 2016. “Precision Cancer Diagnostics: Tracking Genomic Evolution in Clinical Trials.” PLoS Medicine 13 (12): e1002177. doi:10.1371/journal.pmed.1002177. http://dx.doi.org/10.1371/journal.pmed.1002177.1549-1277http://nrs.harvard.edu/urn-3:HUL.InstRepos:29738944In a Perspective, Francisco Beca and Andrew Beck discuss Charles Swanton and colleagues' accompanying Research Article on somatic mutations in patients with inflammatory breast cancer treated in a Phase II clinical trial.en-USMedicine and Health SciencesOncologyCancers and NeoplasmsBreast TumorsBreast CancerCancer TreatmentBiology and Life SciencesGeneticsGenomicsGenomic MedicineMedicine and health sciencesClinical medicineClinical trialsPhase II clinical investigationPharmacologyDrug research and developmentHuman GenomicsClinical MedicineClinical TrialsClinical Trials (Cancer Treatment)Drug Research and DevelopmentMolecular BiologyMolecular Biology TechniquesSequencing TechniquesGenome SequencingInflammatory DiseasesJournal Article2017-01-0310.1371/journal.pmed.1002177